Vanguard Group Inc. lessened its position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 26,030,589 shares of the company’s stock after selling 502,255 shares during the quarter. Vanguard Group Inc. owned approximately 0.13% of Bath & Body Works worth $522,694,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. First Horizon Corp purchased a new position in shares of Bath & Body Works in the 3rd quarter valued at approximately $29,000. Geneos Wealth Management Inc. lifted its stake in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the period. Danske Bank A S purchased a new position in shares of Bath & Body Works in the 3rd quarter valued at approximately $39,000. Advisory Services Network LLC bought a new position in Bath & Body Works during the 3rd quarter valued at approximately $48,000. Finally, Westfuller Advisors LLC bought a new position in Bath & Body Works during the 3rd quarter valued at approximately $56,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.
Analysts Set New Price Targets
A number of research firms recently weighed in on BBWI. Jefferies Financial Group began coverage on Bath & Body Works in a research report on Wednesday, January 14th. They set a “hold” rating and a $24.00 price objective for the company. Zacks Research raised Bath & Body Works from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 20th. Telsey Advisory Group raised their price objective on Bath & Body Works from $23.00 to $25.00 and gave the company a “market perform” rating in a research report on Thursday, March 5th. Citigroup lowered Bath & Body Works from a “buy” rating to a “neutral” rating and raised their price objective for the company from $21.00 to $25.00 in a research report on Tuesday, February 17th. Finally, Barclays raised their price objective on Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, March 2nd. Three research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $23.00.
Bath & Body Works Trading Down 3.3%
Bath & Body Works stock opened at $18.58 on Tuesday. The firm has a market cap of $3.74 billion, a price-to-earnings ratio of 5.90, a PEG ratio of 1.92 and a beta of 1.43. The stock has a fifty day simple moving average of $19.89 and a two-hundred day simple moving average of $21.10. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $34.66.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its earnings results on Wednesday, March 4th. The company reported $2.05 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.28. The business had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.59 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The company’s quarterly revenue was down 2.3% compared to the same quarter last year. During the same quarter last year, the company earned $2.09 EPS. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 2.6 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, March 6th. Shareholders of record on Friday, February 20th were issued a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 20th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.3%. Bath & Body Works’s dividend payout ratio (DPR) is presently 25.40%.
About Bath & Body Works
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
See Also
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
